FC
Farallon Capital Management, L.L.C. disclosed a 7.4% stake in AVTX
Farallon Capital Management, L.L.C. reported owning 7.4% of Avalo Therapeutics, Inc. (AVTX) (3,974,000 shares) in a Schedule 13G filed Nov 13, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 13, 2026
- Source
- Schedule 13G